Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Howard Hughes Medical Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
mBio. 2024 Feb 14;15(2):e0269223. doi: 10.1128/mbio.02692-23. Epub 2024 Jan 16.
A recent study published in by Nemet et al. revealed the critical role played by two gut microbiota members in producing the metabolites indoxyl sulfate (IS) and cresol sulfate (CS) (I. Nemet, M. Funabashi,X. S. Li, M. Dwidar, et al., 2023, mBio 14:e01331-23, https://doi.org/10.1128/mbio.01331-23). Understanding microbial pathways leading to IS and CS production is crucial because they are connected to a pre-thrombotic profile, and having high levels of these metabolites increases the risk of cardiovascular diseases (CVD). Hence, this study can offer vital insights into assessing the risk for CVD and identifying potential treatment targets for this disease.
最近,由 Nemet 等人在《mBio》上发表的一项研究揭示了肠道微生物群的两个成员在产生代谢物吲哚硫酸酯(IS)和愈创木酚硫酸酯(CS)方面的关键作用(I. Nemet、M. Funabashi、X. S. Li、M. Dwidar 等人,2023,mBio 14:e01331-23,https://doi.org/10.1128/mBio.01331-23)。了解导致 IS 和 CS 产生的微生物途径至关重要,因为它们与血栓前特征有关,而这些代谢物水平升高会增加心血管疾病(CVD)的风险。因此,这项研究可以为评估 CVD 风险和确定该疾病的潜在治疗靶点提供重要见解。